Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

UNITED THERAPEUTICS (UTHR) Short-Term Debt issuances: 2014-2022

  • UNITED THERAPEUTICS's Short-Term Debt issuances was N/A to $800.0 million in Q1 2022 from the same period last year, while for Mar 2022 it was $1.3 billion, marking a year-over-year change of. This contributed to the annual value of $800.0 million for FY2022, which is N/A change from last year.
  • As of Q1 2022, UNITED THERAPEUTICS's Short-Term Debt issuances stood at $800.0 million, which was down 0.00% from $800.0 million recorded in Q1 2019.
  • UNITED THERAPEUTICS's 5-year Short-Term Debt issuances high stood at $800.0 million for Q1 2019, and its period low was $800.0 million during Q1 2019.
  • In the last 1 years, UNITED THERAPEUTICS's Short-Term Debt issuances had a median value of $800.0 million in 2022 and averaged $800.0 million.